CFO interim
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
Cadrenal Therapeutics, Inc. reported in a Form 8-K filed June 29, 2026 that John P. Sharp was named Interim Chief Financial Officer, effective June 25, 2026.
In the filing's words
On June 25, 2026, the Board of Directors (the “Board”) of Cadrenal Therapeutics, Inc. (the “Company”) appointed John P. Sharp as Interim Chief Financial Officer of the Company. In connection with the appointment, Quang X. Pham ceased to serve as the Company’s Interim Chief Financial Officer.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Cadrenal Therapeutics, Inc. (CVKD) |
|---|---|
| Event | Interim |
| Incoming | John P. Sharp |
| Outgoing | Quang X. Pham |
| Title in the filing | Interim Chief Financial Officer |
| Effective | June 25, 2026 |
| 8-K filed | June 29, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Senior Director, Lohman & Associates |
| SEC CIK | 0001937993 |
Cadrenal Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 29, 2026. The filing's own words are quoted above.
Before and after at Cadrenal Therapeutics, Inc.
The adjacent records in the company's seat timeline.
Other records naming Quang X. Pham
1The outgoing officer on this record, matched by name. Career line.
5 months ago· 2026-06-03InterimCVKD
Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO
Same industry, June 2026
7Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
5 months ago· 2026-06-18InterimMPLT
MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO
5 months ago· 2026-06-18TransitionPTPI
Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold
5 months ago· 2026-06-15AppointmentSNSE
Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO
5 months ago· 2026-06-12AppointmentOCUL
Ocular Therapeutix, Inc. appoints Jason Robins as CFO
5 months ago· 2026-06-04AppointmentBYSI
BeyondSpring Inc. appoints Na Li as CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about John P. Sharp? Send a correction with the primary source.